Leukemia mortality rates for women in the UK are projected to remain stable at 5.7 per hundred thousand women from 2024 through 2028. This consistent rate suggests no improvement or worsening in leukemia outcomes over the forecast period compared to 2023, where the rate stands the same at 5.7. The year-on-year variation is non-existent, denoting stable mortality predictions, with a zero percent change from 2023 to 2024 and onwards. The five-year compound annual growth rate (CAGR) remains flat.

Future trends to watch for:

Advancements in medical research and treatment options that could impact future mortality rates.
Potential changes in healthcare policies and access to treatment which could influence mortality outcomes.
Emerging health trends or public health initiatives that could alter leukemia mortality statistics.